samedan logo
home > pmps > winter 2020 > a new era for mesh nebulisers
Pharmaceutical Manufacturing and Packing Sourcer

A New Era for Mesh Nebulisers

Nebulisers have been an important device for inhalation therapy since their invention in the 19th century. Throughout the years, different technologies have been developed with the goal of further improving the treatment of respiratory diseases. Today, new devices offer the possibility to generate innovative approaches, overcoming previous limitations and widening the use of nebulisers in areas that have not been explored yet.

The Evolution of Nebulisers

To depict a clearer picture of the evolution of nebulisers, it is essential to start with the invention of the jet nebulisers, which resulted in a massive breakthrough when they were first introduced as a medical device in the respiratory field. This event constituted itself as a pillar that opened a new chapter in the history of inhalation therapy and still has vast implications nowadays. About a century later, in the mid-20th, the ultrasonic nebulisers were introduced with their new features and advantages. The objective of developing this new device was to improve nebulisation experience. However, it was not until the appearance of mesh nebulisers, at the end of the 20th century, that a revolution among nebulisers occurred, catching the attention of professionals in the medical field thanks to the higher levels of efficiency of these devices. Moreover, mesh nebulisers have been proven to broaden the areas of application when compared to their predecessors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
About the author

Hernan Cuevas Brun studied Biomedical Engineering at National Tsing Hua University in Hsinchu, Taiwan, at which he did research focusing on drug delivery for several years. After obtaining an MBA degree, he joined HCmed Innovations where he was appointed as Marketing Manager. He has helped rebrand the mesh nebuliser manufactured by HCmed, which is based on a drug-device combination platform to enhance inhaled drug delivery. Besides working on the marketing strategy of the company, Hernan also collaborates in the participation arrangements of HCmed in four major conferences every year: the Drug Delivery to the Lungs Conference, the European Respiratory Society International Congress, the Respiratory Drug Delivery Conference, and the American Thoracic Society Conference.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Rousselot® Biomedical Announces the Launch of Quali-Pure HGP 2000

Irving, United States, May 4 2022 / Sciad Newswire / Rousselot®, Darling Ingredients’ health brand and the global leader of collagen-based solutions1, launches Quali-Pure™ HGP 2000, a new endotoxin-controlled, pharmaceutical-grade gelatin specifically designed for vaccines and wound healing applications. As the latest addition to Rousselot Biomedical’s rapidly expanding product offering, this new non-gelling hydrolyzed gelatin further extends the scope of biomedical applications covered by Rousselot products.
More info >>

White Papers

Delivering Fit For Purpose Biomanufacturing CHO Cell Lines

Fujifilm Diosynth Biotechnologies

The challenge during mammalian cell line development is to identify and isolate stable, high expressing cell lines producing product with the appropriate critical product quality attributes rapidly, reproducibly and with relative ease. Obtaining a host cell line that inherently exhibits desirable biomanufacturing attributes can therefore have a significantly positive effect on the identification of recombinant cell lines with desired traits during cell line development screens. In this study, we demonstrate that it is possible to exploit intrinsic heterogeneity within host cell populations and identify host cell lines which are more “fit for purpose”.
More info >>

Industry Events

Connect in Pharma

14-15 September 2022, Plaexpo, Geneva, Switzerland

The new event driving innovation for pharma and biopharma businesses, Connect in Pharma will unite key players in Pharmaceutical and Biopharmaceutical packaging and production in Geneva on 14 – 15 September 2022.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement